NCT07373431

Brief Summary

This study aims to identify novel biomarkers for epilepsy development in children with autism and to evaluate the effects of physical exercise on these biomarkers and clinical outcomes. Very little is known about epilepsy biomarkers in children with autism, and the risk of developing epilepsy in this population ranges from 5% to 47%. The project focuses on potential signaling pathways, including immunological factors, synaptic proteins, circadian rhythm genes, sleep architecture, and cognitive function. Children with autism, with or without epilepsy, as well as children with epilepsy, will undergo genetic analyses (exome sequencing) of synaptic and circadian rhythm-related genes, immunological protein profiling, EEG or polysomnography, actigraphy, neuropsychological testing, and physical assessments including coordination, balance, and body awareness. Participants will also engage in a three-month structured physical exercise program. Follow-up assessments will examine the effects of exercise on seizure frequency, biomarker expression, sleep, cognition, and physical abilities. The study addresses two key research questions: 1) whether biomarkers and physiological measures correlate with seizure occurrence in children with autism, and 2) whether regular physical activity can modulate seizure frequency, biomarker expression, circadian rhythm, sleep, cognitive performance, and physical skills. The findings are expected to improve understanding of the mechanisms underlying epilepsy in autism and inform potential interventions.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Sep 2020

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 17, 2020

Completed
2.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2023

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2023

Completed
2 years until next milestone

First Submitted

Initial submission to the registry

January 9, 2026

Completed
19 days until next milestone

First Posted

Study publicly available on registry

January 28, 2026

Completed
Last Updated

January 28, 2026

Status Verified

January 1, 2026

Enrollment Period

2.7 years

First QC Date

January 9, 2026

Last Update Submit

January 20, 2026

Conditions

Keywords

epilepsyautism spectrum disorderBiomarkersImmunological factorsCircadian rhythmCognitive functionPhysical activityExercise interventionSeizures

Outcome Measures

Primary Outcomes (21)

  • Blood sample collection for genetic and protein analyses

    Participants will provide venous blood samples (maximum 10 mL per occasion, up to 2 occasions) for genetic analyses, focusing on synaptic proteins and circadian clock genes (exome sequencing of approximately 600 genes), as well as protein analyses using ELISA, Western blot, or equivalent techniques to assess immunologically associated proteins, including pro- and anti-inflammatory proteins and cell death-related proteins. Biological parents of the children will also provide blood samples for comparison in the genetic analyses. Parental consent for this blood collection will be obtained using a separate consent form.

    Will be conducted at baseline (time of enrollment) and again 1-3 months after completion of the physical exercise intervention, within 6 months from baseline.

  • Actigraphy to evaluate sleep-wake patterns: Sleep latency (minutes)

    Sleep-wake patterns were evaluated using actigraphy. The children were asked to wear an actigraphy watch (MotionWatch 8, CamNtech, UK), which monitors movement and light exposure, for 5-7 days. Sleep latency (minutes) was measured as the duration between the time point the child tries to go to sleep (lights out) and the start of the first block of immobility (presumed fell asleep).

    Will be conducted at baseline (time of enrollment) and again 1-3 months after completion of the physical exercise intervention, within 6 months from baseline.

  • Actigraphy to evaluate sleep-wake patterns: Assumed sleep (hours)

    Actigraphy to evaluate sleep-wake patterns Description: Sleep-wake patterns were evaluated using actigraphy. The children were asked to wear an actigraphy watch (MotionWatch 8, CamNtech, UK), which monitors movement and light exposure, for 5-7 days. Assumed sleep (the sleep period; hours) represents the duration from fell asleep to the end of the last part/block of immobility before getting out of bed (woke up).

    Will be conducted at baseline (time of enrollment) and again 1-3 months after completion of the physical exercise intervention, within 6 months from baseline.

  • Actigraphy to evaluate sleep-wake patterns: Fragmentation Index (index units)

    Sleep-wake patterns were evaluated using actigraphy. The children were asked to wear an actigraphy watch (MotionWatch 8, CamNtech, UK), which monitors movement and light exposure, for 5-7 days. Fragmentation Index (index units) is used to measure sleep quality, composed of the percentage of measured mobile time and immobile bouts with a duration ≤1 min, during assumed sleep.

    Will be conducted at baseline (time of enrollment) and again 1-3 months after completion of the physical exercise intervention, within 6 months from baseline.

  • Actigraphy to evaluate sleep-wake patterns: Wake Bouts (seconds)

    Sleep-wake patterns were evaluated using actigraphy. The children were asked to wear an actigraphy watch (MotionWatch 8, CamNtech, UK), which monitors movement and light exposure, for 5-7 days. Wake bouts (seconds) means single episodes of wakefulness during the sleep period. Total daytime activity score (score units) was defined by the sum of the activity counts during wakefulness..

    Will be conducted at baseline (time of enrollment) and again 1-3 months after completion of the physical exercise intervention, within 6 months from baseline.

  • Actigraphy to evaluate sleep-wake patterns: Total Activity Score (score units)

    Actigraphy to evaluate sleep-wake patterns: Wake Bouts (seconds) Description: Sleep-wake patterns were evaluated using actigraphy. The children were asked to wear an actigraphy watch (MotionWatch 8, CamNtech, UK), which monitors movement and light exposure, for 5-7 days. Total daytime activity score (score units) was defined by the sum of the activity counts during wakefulness.

    Will be conducted at baseline (time of enrollment) and again 1-3 months after completion of the physical exercise intervention, within 6 months from baseline.

  • Autism Spectrum Screening Questionnaire (ASSQ)

    ASSQ is a screening questionnaire for autism spectrum disorder, containing 27 questions or statements assessing behaviors related to ASD. The ratings available are "no" (0 point), "somewhat" (1 point), "yes" (2 points). The points are added up to a total score of maximum 54 points. For a clinical population the score 19 are used as a cutoff to indicate autism spectrum disorder.

    Will be conducted at baseline (time of enrollment) and again 1-3 months after completion of the physical exercise intervention, within 6 months from baseline.

  • Behavior Rating Inventory of Executive Function , Second Edition (BRIEF-2)

    BRIEF measuring executive functions and self-regulation in children and adolescents ages 5-18 in the parent form. The questionnaire consists of 63 statements and nine clinical scales: inhibition, self-monitor, shift, emotional control, initiate, working memory, plan/organize, task-monitor and organizing of materials. These scales are distributed under three domains: behavioral index, emotional index and cognitive index. The global executive composite (GEC) averages all assessment values. The rater records their answer via a Likert-type format N (never), S (sometimes) or O (often). Results are presented in T-score format (M=50, SD=10) and a higher T-score suggests that the child exhibits significant difficulties with executive functions. The results could also be compared to age-matched norms. Cut-off scores: 60-64 mildly elevated; 65-69 potentially clinically elevated; ≥70 clinically elevated difficulties.

    Will be conducted at baseline (time of enrollment) and again 1-3 months after completion of the physical exercise intervention, within 6 months from baseline.

  • Child Sensory Profile (CSP)

    CSP is an assessment to evaluate a child's sensory processing patterns in different environments and how they impact on daily functioning. The parent form can be used for children ages 3-14 years. It consists of 86 statements and the parent record their answer by choosing between "almost always", "frequently", "half of the time", "occasionally", "almost never" or "does not apply". Most of the items are counted under one of the quadrants: seeking (the degree to which a child obtains sensory input), avoiding (the degree to which a child is bothered by sensory input), sensitivity (the degree to which a child detects sensory input) and registration (the degree on which a child misses sensory input). The form also provides information about how the child processes different modalities of sensory inputs divided into the following sensory sections: auditory, visual, touch, movement, body position and oral. Behavioral responses related to sensory inputs are divided into the following behavior

    Will be conducted at baseline (time of enrollment) and again 1-3 months after completion of the physical exercise intervention, within 6 months from baseline.

  • Social Responsiveness Scale (SRS)

    SRS aims to identify social impairment associated with ASD and quantify its severity. The school age form applies for parents to children and adolescents ages 4-18 years. It consists of 65 items which are rated on a graduated response scale: "never true", "sometimes true", "often true" and "almost always true". Five subscales are used for evaluating treatment: social awareness, social cognition, social communication, social motivation and restricted interest and repetitive behavior. The subscales are preferably not used for screening or diagnosis. The total and subscale scores are compared to clinical cut-offs indicating presence of autism-related social impairments; 60-75 mild to moderate social impairment; ≥76 severe social impairment.

    Will be conducted at baseline (time of enrollment) and again 1-3 months after completion of the physical exercise intervention, within 6 months from baseline.

  • Strengths and Difficulties Questionnaire (SDQ)

    SDQ is an emotional and behavioral screening questionnaire for parents to children and adolescents ages 4-17 years. It consists of 33 questions or statements and the responder records their answer for the first 25 items on the response scale: "not true", "somewhat true" or "certainly true". The remaining items address the severity and the duration of the difficulties. The first 25 items asses five scales: emotional symptoms, conduct problems, hyperactivity/inattention, peer relationship problems and prosocial behavior. The total score helps to categorize the child or adolescent as having "normal", "borderline" or "abnormal" difficulties. For the subscales there are clinical cut-off scores.

    Will be conducted at baseline (time of enrollment) and again 1-3 months after completion of the physical exercise intervention, within 6 months from baseline

  • Swanson, Nolan, and Pelham 26-item Rating Scale (SNAP-IV)

    SNAP-IV is a 30-item rating scale for parents to assess symptoms of ADHD (inattention and hyperactivity/impulsivity) and symptoms of oppositional defiant disorder, based on the DSM criteria. It is divided into subscales for inattention, hyperactivity/impulsivity, and oppositional behavior. Symptom severity is rated on a 4-point scale: not at all (0), just a little (1), quite a bit (2) and very much (3). Subscale scores are calculated and compared to clinical cut-off scores. ≥ 1.67 indicates clinical difficulties for combinated inattention + hyperactivity/impulsivity.

    Will be conducted at baseline (time of enrollment) and again 1-3 months after completion of the physical exercise intervention, within 6 months from baseline.

  • Cognitive testing with CANTAB: Intra-Extra Dimensional Set Shift (IED)

    For cognitive assessment, all children underwent a selection of tests from the computerized Cambridge Neuropsychological Test Automated Battery (CANTAB). IED includes 27 outcome measures to evaluate rule acquisition and reversal, requiring visual discrimination, attentional set formation, maintenance, shifting, and attention flexibility. The participant must work out a rule that determines which stimulus is correct. After six correct responses, the stimuli and/or rule changes. Outcome measure assess the number of stages completed, the numbers of trials completed, the number of errors made and response latency. Outcome measurements as they are described in CANTAB Connect Research: Admin Application User Guide, Cambridge Cognition limited 2022, V1.25. Note that each test has several more outcome measurements that we excluded in our analysis.

    Will be conducted at baseline (time of enrollment) and again 1-3 months after completion of the physical exercise intervention, within 6 months from baseline.

  • Cognitive testing with CANTAB: Paired Association Learning (PAL)

    For cognitive assessment, all children underwent a selection of tests from the computerized Cambridge Neuropsychological Test Automated Battery (CANTAB). With 21 outcome measures, the PAL test evaluates visual memory and new learning abilities. Boxes are displayed and one or more of them contains a pattern. The patterns are then displayed in the middle and the participant must select the box containing the same pattern. Outcome measurements are stages completed, memory scores, the errors made, and the number of trials required to locate the patterns.

    Will be conducted at baseline (time of enrollment) and again 1-3 months after completion of the physical exercise intervention, within 6 months from baseline.

  • Cognitive testing with CANTAB: Reaction Time (RTI)

    Comprising 21 outcome measures, this test assesses motor and mental response speed, as well as movement time, reaction time, response accuracy, and impulsivity. The participant must select and hold a button while circles are presented on the screen. When a circle with a yellow dot in it appears, the participant must react as fast as possible and select the circle with the dot in it. Outcome measures are reaction time and movement time.

    Will be conducted at baseline (time of enrollment) and again 1-3 months after completion of the physical exercise intervention, within 6 months from baseline.

  • Cognitive testing with CANTAB: Stockings of Cambridge (SOC)

    Featuring 27 outcome measures, the SOC test assesses spatial planning and problem-solving strategy formulation. The participant is requested to move balls to copy a pattern and use as few moves as possible. Movement time is discounted in a part of the task where the participants just copy the movements made by the computer which mimics the movements the participant made when solving the original problem. Outcome measures include difficulty level reached, mean moves used and thinking time.

    Will be conducted at baseline (time of enrollment) and again 1-3 months after completion of the physical exercise intervention, within 6 months from baseline.

  • Cognitive testing with CANTAB: Spatial Working Memory (SWM)

    The SWM test, with 24 outcome measures, assesses the retention and manipulation of visuospatial information, providing measures of strategy use and working memory. The participant is requested to select the boxes and using a process of elimination to find a token in each of a number of boxes. The number of boxes gradually increases, and the color and position of the boxes changes between trials. Outcome measures include different type of errors and strategy.

    Will be conducted at baseline (time of enrollment) and again 1-3 months after completion of the physical exercise intervention, within 6 months from baseline.

  • Evaluation of the intervention

    Semi-structured or structured interviews with participants and/or parents.

    After completion of the intervention, within 6 months from baseline.

  • Sleep Electroencephalogram (EEG): Posterior Dominant Rhythm (Hz)

    Participants will undergo a sleep EEG recording lasting approximately 40 minutes to assess brain electrical activity during sleep, to measure posterior Dominant Rhythm in Hertz (Hz), which is the main background alpha frequency.

    Will be conducted at baseline (time of enrollment) and again 1-3 months after completion of the physical exercise intervention, within 6 months from baseline.

  • Sleep Electroencephalogram (EEG): Interictal epileptiform activity (IEA)

    Participants will undergo a sleep EEG recording lasting approximately 40 minutes to assess brain electrical activity during sleep, to measure IEA; the frequency of interictal epileptiform activity was assessed and graded as rare, moderate, or frequent.

    Will be conducted at baseline (time of enrollment) and again 1-3 months after completion of the physical exercise intervention, within 6 months from baseline.

  • Sleep Electroencephalogram (EEG): Sleep Spindles (counts)

    Participants will undergo a sleep EEG recording lasting approximately 40 minutes to assess brain electrical activity during sleep, to measure sleep spindles; number of sleep spindles during the first 5 minutes following the first vertex wave, as well as after the occurrence of the first sleep spindle after sleep onset.

    Will be conducted at baseline (time of enrollment) and again 1-3 months after completion of the physical exercise intervention, within 6 months from baseline.

Study Arms (1)

Physical activity intervention program

EXPERIMENTAL

Participants will engage in a structured physical exercise program conducted in small groups, 1-3 times per week, over 8-12 weeks. Each session lasts up to 1 hour and includes heart-rate-raising aerobic activities followed by a relaxation period.

Behavioral: Physical activity program

Interventions

Participants will engage in a structured physical exercise program conducted in small groups, 1-3 times per week, over 8-12 weeks. Each session lasts up to 1 hour and includes heart-rate-raising aerobic activities followed by a relaxation period.

Physical activity intervention program

Eligibility Criteria

Age10 Years - 15 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Children aged 10-15 years
  • Diagnosed with mild-to-moderate autism spectrum disorder and/or diagnosed with epilepsy

You may not qualify if:

  • Severe autism spectrum disorder
  • Severe cognitive impairment
  • Severe ADHD
  • Active systemic inflammatory or neurodegenerative disease
  • Traumatic brain injury within the past 6 months

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Div. Clinical Neurophysiology, Dept Clinical Sciences, Lund University, SE-221 85 Lund, Sweden

Lund, Sweden

Location

MeSH Terms

Conditions

EpilepsyAutism Spectrum DisorderMotor ActivitySeizures

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System DiseasesChild Development Disorders, PervasiveNeurodevelopmental DisordersMental DisordersBehaviorNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Christine T Ekdahl, Associate professor

    Div. Clinical Neurophysiology, Dept Clinical Sciences, Lund University & Clinical Neurophysiology, Department of Medical Imaging and Physiology, Skåne University Hospital, Lund, Sweden.

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 9, 2026

First Posted

January 28, 2026

Study Start

September 17, 2020

Primary Completion

June 1, 2023

Study Completion

December 31, 2023

Last Updated

January 28, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will not share

We do not plan to share individual participant data. This is an exploratory study with a small number of participants, and sharing the data could potentially compromise participant confidentiality.

Locations